Skip to main content

Swift Biosciences' TP53 Panel

Swift Biosciences has launched an early access program for its next-generation sequencing-based TP53 Panel that covers all coding exons of the gene. The panel uses Swift's Accel-NGS Amplicon Panel technology and runs on Illumina's sequencing instruments. In addition, it is planning another panel using the Accel-NGS Amplicon technology that will target over 200 clinically relevant cancer mutations.

 
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.